Ciprofloxacin resistance in clinical isolates of Pseudomonas aeruginosa from Italian patients. 1995

G Corti, and F Paradisi, and E Giganti, and G Buffini, and E Tortoli, and L Martelli, and P Pecile, and P Nicoletti
Infectious Disease Clinic, University of Florence, Italy.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents

Related Publications

G Corti, and F Paradisi, and E Giganti, and G Buffini, and E Tortoli, and L Martelli, and P Pecile, and P Nicoletti
June 2023, Contact lens & anterior eye : the journal of the British Contact Lens Association,
G Corti, and F Paradisi, and E Giganti, and G Buffini, and E Tortoli, and L Martelli, and P Pecile, and P Nicoletti
October 2003, The British journal of ophthalmology,
G Corti, and F Paradisi, and E Giganti, and G Buffini, and E Tortoli, and L Martelli, and P Pecile, and P Nicoletti
December 2008, Journal of chemotherapy (Florence, Italy),
G Corti, and F Paradisi, and E Giganti, and G Buffini, and E Tortoli, and L Martelli, and P Pecile, and P Nicoletti
August 2007, Journal of chemotherapy (Florence, Italy),
G Corti, and F Paradisi, and E Giganti, and G Buffini, and E Tortoli, and L Martelli, and P Pecile, and P Nicoletti
June 2005, Antimicrobial agents and chemotherapy,
G Corti, and F Paradisi, and E Giganti, and G Buffini, and E Tortoli, and L Martelli, and P Pecile, and P Nicoletti
February 2001, Antimicrobial agents and chemotherapy,
G Corti, and F Paradisi, and E Giganti, and G Buffini, and E Tortoli, and L Martelli, and P Pecile, and P Nicoletti
September 1988, The Journal of infectious diseases,
G Corti, and F Paradisi, and E Giganti, and G Buffini, and E Tortoli, and L Martelli, and P Pecile, and P Nicoletti
November 2007, Japanese journal of infectious diseases,
G Corti, and F Paradisi, and E Giganti, and G Buffini, and E Tortoli, and L Martelli, and P Pecile, and P Nicoletti
January 2021, Iranian journal of pathology,
G Corti, and F Paradisi, and E Giganti, and G Buffini, and E Tortoli, and L Martelli, and P Pecile, and P Nicoletti
January 2006, Pathologie-biologie,
Copied contents to your clipboard!